NCT07309770 2025-12-30Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard TherapiesFudan UniversityPhase 2 Recruiting90 enrolled
NCT00082706 2025-09-09Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantM.D. Anderson Cancer CenterPhase 2 Active not recruiting46 enrolled
NCT06683846 2025-08-24Ivonescimab in the Treatment of Multiple Advanced TumorsFudan UniversityPhase 2 Recruiting400 enrolled
NCT06638931 2025-05-28ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Active not recruiting28 enrolled
NCT06684327 2024-12-20Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced TumorsFudan UniversityPhase 2 Recruiting100 enrolled
NCT04611724 2020-11-02A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus CancerAsan Medical CenterPhase 2 Unknown35 enrolled